   |
  |
The 2011 Edith and Peter O'Donnell Awards RecipientsTo view videos of the recipients, click on the names below. The 2011 Edith and Peter O'Donnell Award in MedicineMargaret (“Peggy”) Goodell is a Professor and Director of the Stem Cells and Regenerative Medicine Center at Baylor College of Medicine in Houston, Texas. Goodell received her doctorate from Cambridge University in England and underwent post-doctoral training at MIT and Harvard Medical School. At MIT, she developed a novel method for isolating blood forming stem cells from mouse bone marrow based on a fortuitous observation that stem cells efflux fluorescent lipophillic dyes. This method has become widely used to isolate somatic stem cells from a variety of species and tissues, including from cancer stem cells. Her current research is focused on the fundamental mechanisms that regulate hematopoietic stem cells. Goodell has been on the faculty at Baylor College of Medicine since 1997 as a member of the Center for Cell and Gene Therapy, and the Departments of Pediatrics, Molecular & Human Genetics, and Immunology. She holds the Vivian L. Smith Chair in Regenerative Medicine. She received the DeBakey Award for Excellence in Research in 2004 and the Stohlman Scholar Award from the Leukemia and Lymphoma Society in 2006. Goodell has served on the board of the International Society for Stem Cell Research (2005-2008) and the International Society for Experimental Hematology (2009-2012). She is on the editorial boards of Blood, Cell Stem Cell and PLoS Biology, and serves as a reviewer for multiple journals and granting agencies. Goodell directs a laboratory of about 20 students and post-doctoral fellows.
The 2011 Edith and Peter O'Donnell Award in Engineering
J.-C. Chiao, a pioneer in the integration of multidisciplinary research fields covering electrical and mechanical engineering, optics, microfabrication, nanotechnology and biotechnology for clinical medicine, is a Professor of Electrical Engineering at The University of Texas at Arlington, graduate faculty in the Biomedical Engineering Program, and an Adjunct Associate Professor of Internal Medicine at The University of Texas Southwestern Medical Center at Dallas. He received his Bachelor of Science in Electrical Engineering from National Taiwan University and his doctorate in Electrical Engineering from California Institute of Technology under Professor David Rutledge. J.-C. served as Research Scientist in the Optical Networking and Testbeds group at Bellcore (now Telcordia), Assistant Professor of Electrical Engineering at University of Hawaii - Manoa, Visiting Professor at Tohoku University and RIKEN, and Product Line Manager and Senior Technology Advisor at Chorum Technologies. He joined UT Arlington in 2002. J.-C. has published and edited numerous peer-reviewed papers and proceedings. He holds 4 awarded and several pending patents in RF MEMS (radio frequency microelectromechanical system), optical MEMS, liquid crystal and medical devices. He chaired six international conferences, co-founded the American Academy of Nanomedicine, served on the editorial board of the journal Nanomedicine: Nanotechnology, Biology and Medicine, and served as Associate Editor for the Journal of Nanotechnology in Engineering and Medicine. J.-C.’s research works have been recognized in the RF MEMS fields and millimeterwave components. J.-C.’s current research focuses on utilizing MEMS techniques and telemetric electronics in the development of miniature implantable sensors and devices to monitor physiological parameters for diagnosis and provide therapeutic treatment in clinical applications for conditions such as gastroesophageal and neuro-disorders, and novel assays to assess the potential risk of developing metastasis in cancer patients.
The 2011 Edith and Peter O'Donnell Award in ScienceKim Orth is an Associate Professor in Molecular Biology at The University of Texas Southwestern Medical Center at Dallas, where she is also a W.W. Caruth Jr. Scholar in Biomedical Research. She received a Bachelor of Science in Biochemistry from Texas A&M University and a Master of Science in Biological Chemistry from UCLA followed by a doctorate in Biochemistry and Molecular Genetics from UT Southwestern Medical Center. After postdoctoral studies at University of Michigan, Dr. Orth joined the faculty at UT Southwestern Medical Center in 2001, where she has since been awarded an Arnold and Mabel Beckman Young Investigator Award in 2003, a Burroughs Wellcome Investigator in Pathogenesis of Infectious Disease in 2006 and the Welch Foundation Norman Hackerman Award in Chemical Science in 2010. Kim’s lab is interested in elucidating the activity of virulence factors (also called effectors) from pathogenic bacteria to gain novel molecular insight into eukaryotic signaling systems. Many of these effectors have usurped mammalian cell activity that is critical for a mammalian host cell to maintain homeostasis. After copying this activity from the host, the bacterial pathogens deregulate these important signaling molecules so that they can be used by the pathogen during an infection. Her lab wants to understand the activity of these usurped molecules because they will ultimately reveal sensitive mechanisms that, when altered, change the fate of a host cell. Based on this hypothesis, her lab has uncovered multiple novel activities that are extremely important signaling mechanisms, including discoveries in the regulation of innate immunity, dynamics of the actin cytoskeleton and maintenance of cell membrane integrity. These discoveries and future discoveries from the Orth lab contribute to the collective knowledge of basic biological systems that will benefit future studies in medical science.
The 2011 Edith and Peter O'Donnell Award in Technology Innovation
Duncan G. Hudson III is the Director of LabVIEW Core R&D at National Instruments in Austin, Texas. He received his master’s degree in Computer Science at The University of Texas at Austin in 1989. He joined the LabVIEW R&D group at National Instruments in 1992 and has led the development of the LabVIEW graphical programming language for science and engineering since 1998. David W. Fuller III is the Director of LabVIEW Platform R&D at National Instruments in Austin, Texas. He received his bachelor’s degree in Computer Science and Computer Engineering from Texas A&M University in 1995, graduating cum laude. He joined National Instruments full-time in 1995 and served as a software developer for five years during which time he gained deep knowledge of Industrial Embedded systems and their IO models. In 2000, David moved into an R&D management role and is currently leading efforts to drive LabVIEW into the Industrial and Embedded market spaces. LabVIEW is used worldwide by most major research universities, research institutes, and major companies to enable domain experts in science and engineering to rapidly design, prototype and deploy their innovations. Applications range from particle beam control in the CERN Large Hadron Collider, to heart rate monitoring, to robot control systems, to WiMax communication system design. Since 1998, with the introduction of LEGO RoboLab, a derivative of the LabVIEW language for use with LEGO Mindstorms hardware, LabVIEW has risen to prominence in K-12 science and engineering education. LabVIEW is currently enabling tens of thousands of high school students each year to engage in hands-on engineering through the FIRST Robotics Competition.
|
